Why S&P Bulls Should Temper Their Expectations

The Fed is expected to cut interest rates

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     10/30/2019
Tiny Biotech Wins $75 Billion Patent Tiny biotech firm wins $2 billion patent for new treatment that can "Cut & Paste" cancer from your body. The Wall Street Journal reports this breakthrough is "transforming medicine." Our research proves that anyone who gets in by October 25th could turn $1,000 into $1.57 million (or more).
Dow Futures Higher Ahead of Fed Decision By Josh Selway Share On U.S stock futures are pointing to a higher open ahead of a huge day on Wall Street. Investors are gearing up for the Fed's rate-cut decision this afternoon, and the subsequent press conference from Fed Chair Jerome Powell. Until then, traders will be monitoring more corporate earnings reports, including a strong quarterly update from General Electric (GE), which has the former Dow Jones Industrial Average (DJI) component rallying ahead of the opening bell. Many will remain glued in after the close, as well, with tech giants Apple (AAPL) and Facebook (FB) set to release their earnings reports. Continue reading for more on today's market, including:  Schaeffer's Senior Quantitative Analyst Rocky White explains why the next six months may not be as bullish as usual for stocks. 2 reasons an analyst likes Slack stock. Why the Applied Materials rally could go on for weeks. Plus, Crocs nails back-to-school season; Biogen stays in focus; and a penny stock to watch. >> Continue reading...
LATEST HEADLINES
>> S&P Approaching Most Bullish 6 Months of the Year However, traders should temper their expectations this time around >> S&P Cools as Wall Street Looks to Fed Meeting The index did hit another record high earlier, while the Dow waffled before closing lower >> WORK Attracts Options Bulls After Analyst Nod Piper Jaffray initiated coverage on WORK stock with an "outperform" rating >> 3 Grocery Stocks Sinking on Amazon Prime News Amazon said it will offer free grocery delivery to U.S. Prime members >> Call Traders Gear Up for More AMAT Stock Upside An internal study shows Applied Materials stock could keep gaining Sponsored Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com